Navigation Links
A Settlement Over Stem Cell Controversy Through Scientific Research

The successful attempts of scientists to create stem cells that resemble those of the embryonic origin, in addition to reprogramming to the embryonic state could eliminate the need for creation and destruction of human embryos for the same. //

If future experiments are directed to ensure that this reprogrammed state would be maintained even after removal of the embryonic stem cell DNA, currently a technical hurdle, the hybrid cells could theoretically be used to produce embryonic stem cells lines that are tailored to individual patients without the need to exploit human embryos.

The hybrid cells created by the team had the appearance, growth rate, and several key genetic characteristics of human embryonic cells. They also behaved like embryonic cells, differentiating into cells from each of the three main tissue types that form in a developing embryo.

This would not only save the embryos from being used for scientific purposes but also eliminate the controversy that exists over stem cell research at the present, circumventing some of the logistical and societal concerns. The above study has used laboratory grown human embryonic stem cells that have already been approved for use by federally funded researchers.

Not much is known about the feasibility of the procedure presently, but has led to an understanding that human embryonic cells have the ability to reprogram adult cell chromosomes following cell fusion.
'"/>




Page: 1

Related medicine news :

1. Is Workers’ Comp. Settlements for Back Pain Fair
2. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
3. Herbal Drug In Controversy
4. The Existing Controversy of Hormone Replacement Therapy
5. Controversy over spread of Mad Cow disease from India
6. French Fries In Cancer Controversy In China
7. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
8. Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?
9. The Looming Controversy Surrounding Facial Transplant
10. Controversy over Healthy diet may lead to less red meat in diet
11. Controversy over Copeman Healthcare fee
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... ... Center is now offering various types of dental implants to restore lost teeth. Dental implants ... such as crowns, bridges, or dentures. An implant is placed directly into the jawbone where ... tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for ... the hiring of Richard Robinson as chief operating officer (COO). In this role, ... a proven track record of simplifying business processes and developing growth strategies to ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... leakage is revolutionizing the way women look and feel about themselves and their ... of female sexual dysfunction and urinary leakage head on with a ground breaking ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with ... Angela Cotey, with or without a referral. Dr. Cotey is a trusted dentist who ... preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: